Diagnostic and prognostic implications of endotoxemia in critical illness: Results of the MEDIC study

Journal of Infectious Diseases

Volumn 190, Issue 3, 2004, Pages 527-534

  Marshall, John C ^a,m   Foster, Debra ^d   Vincent, Jean Louis ^f   Cook, Deborah J ^e   Cohen, Jonathan ^k   Dellinger, R Phillip ^i,l   Opal, Steven ^g   Abraham, Edward ^h   Brett, Stephen J ^j   Smith, Terry ^b   Mehta, Sangeeta ^c   Derzko, Anastasia ^d   Romaschin, Alex ^a,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Spectral Diagnostics   (Canada)

^e ST JOSEPH S HOSPITAL   (Canada)

^f ERASME HOSPITAL   (Belgium)

^g BROWN UNIVERSITY   (United States)

^h UNIVERSITY OF COLORADO   (United States)

ⁱ RUSH UNIVERSITY MEDICAL CENTER   (United States)

^j HAMMERSMITH HOSPITAL   (United Kingdom)

^k UNIVERSITY OF BRIGHTON   (United Kingdom)

^l RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^m TORONTO GENERAL HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BACTERIAL INFECTION; CRITICAL ILLNESS; ENDOTOXEMIA; FEMALE; GRAM NEGATIVE ANAEROBIC BACTERIA; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY BURST;

ADULT; AGED; ANIMALS; APACHE; CHEMILUMINESCENT MEASUREMENTS; COHORT STUDIES; CRITICAL ILLNESS; ENDOTOXEMIA; ENDOTOXINS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; MALE; MICE; MIDDLE AGED; PREVALENCE; PROGNOSIS; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 3042785468     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/422254     Document Type: Article

References (32)

1. Ulevitch RJ, Tobias PS. Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 1999; 11:19-22.
2. Zhao B, Bowden RAS, Stavchansky SA, Bowman PD. Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays. Am J Physiol Cell Physiol 2001; 281:C1587-95.
3. Fessler MB, Malcolm KC, Duncan MW, Worthen GS. A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase. J Biol Chem 2002; 277:31291-302.
4. Rietschel ET, Brade H, Holst O, et al. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 1996; 216:39-81.
5. Natanson C, Eichenholz PW, Danner RI, et al. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989; 169:823-32.
6. Suffredini AF, Fromm RE, Parker MM, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321:280-7.
7. Lin E, Lowry SF. The human response to endotoxin. Sepsis 1998; 2:255-62.
8. Taveira Da Silva AM, Kaulach HC, Chuidian FS, Lambert DR, Stuffredini AF, Danner RL. Brief report: shock and multiple organ dysfunction after self administration of salmonella endotoxin. N Engl J Med 1993; 328:1457-60.
9. Raetz CRH, Ulevitch RJ, Wright SD, Sibley CH, Ding A, Nathan CF. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J 1991; 5:2652-60.
10. Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parrillo JE. Endotoxemia in human septic shock. Chest 1991; 99:169-75.
11. Bates DW, Parsonnet J, Ketchum PA, et al. Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. Clin Infect Dis 1998; 27:582-91.
12. Opal SM, Scannon PJ, Vincent JL, et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 1999; 180:1584-9.
13. Van Deventer SJH, Ten Cate JW, Tytgat GNJ. Intestinal endotoxemia: clinical significance. Gastroenterology 1988; 94:825-31.
14. Jeukendrup AE, Vet-Joop K, Sturk A, et al. Relationship between gastrointestinal complaints and endotoxaemia, cytokine release and the acute-phase reaction during and after a long-distance triathlon in highly trained men. Clin Sci (Lond) 2000; 98:47-55.
15. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999; 115:829-35.
16. Nahum A, Hoyt J, Schmitz L, Moody J, Shapiro R, Marini JJ. Effect of mechanical ventilation strategy on dissemination of intratracheally instilled Escherichia coli in dogs. Crit Care Med 1997; 25:1733-43.
17. Cohen J, McConnell JS. Observations on the measurement and evaluation of endotoxemia by a quantitative limulus lysate microassay. J Infect Dis 1984; 150:916-24.
18. Levin J, Bang FB. Clottable protein in Limulus: its localization and kinetics of its coagulation by endotoxin. Thromb Diath Haemorrh 1968; 19:186-97.
19. Cohen J. The detection and interpretation of endotoxemia. Intensive Care Med 2000; 26 (Suppl 1):S51-6.
20. Sands KE, Bates DW, Lanken PN, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997; 278:234-40.
21. Romaschin AD, Harris DM, Ribeiro MB, et al. A rapid assay of endotoxin in whole blood using autologous neutrophil-dependent chem-iluminescence. J Immunol Methods 1998; 212:169-85.
22. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-40.
23. Bone RC, Fisher CJ, Clemmer TP, et al. Sepsis syndrome: a valid clinical entity. Crit Care Med 1989; 17:389-93.
24. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-29.
25. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23:1638-52.
26. Vincent JL, Moreno R, Takala J, et al. The sepsis-related organ failure assessment (SOFA) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22:707-10.
27. Marshall JC. Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nat Rev Drug Discov 2003; 2:391-405.
28. Poelstra K, Bakker WW, Klok PA, Kamps JA, Hardonk MJ, Meijer DK. Dephosphorylation of endotoxin by alkaline phosphatase in vivo. Am J Pathol 1997; 151:1163-9.
29. Novitsky TJ. Limitations of the Limulus amebocyte lysate test in demonstrating circulating lipopolysaccharides. Ann NY Acad Sci 1998; 851:416-21.
30. Roumen RMH, Frieling JTM, van Tits HWHJ, et al. Endotoxemia after major vascular operations. J Vasc Surg 1993; 18:853-7.
31. Ziegler EJ, Fisher CJ, Sprung CL, et al. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 1991; 324:429-36.
32. McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR, the CHESS Trial Study Group. Treatment of septic shock with human monoclonal antibody HA-1A: a randomized double-blind, placebo-controlled trial. Ann Intern Med 1994; 121:1-5.